Ameriprise Financial Inc Arcutis Biotherapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 89,267 shares of ARQT stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,267

Previous 77,406 15.32%

Holding current value

$1.26 Million

Previous $719,000 15.44%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.32 - $11.0 $98,683 - $130,471	11,861 Added 15.32%	89,267 $830,000
Q2 2024 Aug 14, 2024	SELL	$7.24 - $12.53 $119,706 - $207,171	-16,534 Reduced 17.6%	77,406 $719,000
Q1 2024 May 15, 2024	SELL	$3.25 - $11.77 $3.2 Million - $11.6 Million	-985,640 Reduced 91.3%	93,940 $930,000
Q4 2023 Feb 14, 2024	BUY	$1.84 - $4.82 $1.99 Million - $5.2 Million	1,079,580 New	1,079,580 $3.49 Million
Q2 2023 Aug 14, 2023	SELL	$7.51 - $15.0 $3.89 Million - $7.77 Million	-517,682 Reduced 60.57%	337,052 $3.21 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $420,575 - $704,659	41,112 Added 5.05%	854,734 $9.4 Million
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $2.22 Million - $3.24 Million	158,944 Added 24.28%	813,622 $12 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $1.97 Million - $2.98 Million	110,490 Added 20.3%	654,678 $12.5 Million
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $1.86 Million - $2.53 Million	113,926 Added 26.48%	544,188 $11.6 Million
Q1 2022 May 16, 2022	BUY	$14.38 - $22.79 $3.08 Million - $4.87 Million	213,859 Added 98.82%	430,262 $8.29 Million
Q4 2021 Feb 14, 2022	SELL	$14.98 - $25.5 $2.18 Million - $3.71 Million	-145,632 Reduced 40.23%	216,403 $4.49 Million
Q3 2021 Nov 15, 2021	BUY	$19.28 - $27.1 $137,948 - $193,900	7,155 Added 2.02%	362,035 $8.66 Million
Q2 2021 Aug 16, 2021	BUY	$24.42 - $34.75 $920,072 - $1.31 Million	37,677 Added 11.88%	354,880 $9.69 Million
Q1 2021 May 17, 2021	BUY	$24.47 - $36.98 $4.95 Million - $7.47 Million	202,086 Added 175.55%	317,203 $9.18 Million
Q4 2020 Feb 12, 2021	SELL	$17.82 - $31.73 $3.02 Million - $5.37 Million	-169,329 Reduced 59.53%	115,117 $3.24 Million
Q3 2020 Nov 16, 2020	BUY	$23.44 - $32.28 $150,648 - $207,463	6,427 Added 2.31%	284,446 $8.33 Million
Q2 2020 Aug 14, 2020	BUY	$24.48 - $36.56 $577,238 - $862,084	23,580 Added 9.27%	278,019 $8.41 Million
Q1 2020 May 15, 2020	BUY	$18.5 - $36.9 $4.71 Million - $9.39 Million	254,439 New	254,439 $7.58 Million

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $849M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Arcutis Biotherapeutics, Inc. Transaction History